← FDA Drug Approvals (Drugs@FDA)
LEVETIRACETAM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2022-03-28
Drug application
- FDA Application #
ANDA209474- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LEVETIRACETAM
- Generic name
- LEVETIRACETAM
- Active ingredients
- LEVETIRACETAM
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- PRINSTON INC
- Manufacturer
- Solco Healthcare US, LLC
- First approval
- 2022-03-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown